Cite

HARVARD Citation

    Patsouris, A. et al. (2021). Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation. European journal of cancer. pp. 283-295. [Online]. 
  
Back to record